Company intelligence / Profile preview

ADNTRO Genetics

Ownership: Private
Development stage: Commercial

Overview

ADNTRO Genetics offers commercial direct-to-consumer DNA testing kits that provide comprehensive reports on ancestry, health risks, nutrigenetics, pharmacogenetics, fitness traits, and more. Their platform uses advanced bioinformatics algorithms—including proprietary polygenic risk scoring—and leverages large-scale databases like the UK Biobank. The service includes regular updates as new scientific findings emerge. No clinical trial results are reported as they do not develop therapeutics.

Therapeutic areas: OtherPsychiatryMetabolic Disorders
Modalities: Genetic testing (genotyping)Next-generation sequencing (NGS)Polygenic risk scoring
Industry: Molecular Diagnostics

Partnerships

University of Texas at Tyler (collaboration on ancestry research)Uses UK Biobank data for validation of PRS algorithms

Beyond the preview

Go deeper on ADNTRO Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADNTRO Genetics.

Explore the full profile